Anders Schultz, MD, FRCPC Edmonton, AB, Canada Send page to friend via: Share via:
In a functional medicine practice, a clinician might consider a conversation about GHK Cu if someone: Is already addressing foundational longevity drivers (sleep, strength training, protein, glucose regulation) Has skin or connective tissue goals and wants evidence informed support Is in a repair phase after a period of high stress, illness, or inflammatory burden, and foundations are stable Wants a careful, monitored approach rather than internet protocols And we would still want to ask: What is your mineral status and overall nutrition status
[General protein/peptide stability reference] Lam XM, et al
While branded GLP-1 medications often have specific criteriasuch as a BMI of 30 or higher, or 27 with weight-related health conditionscompounded medications allow greater flexibility